This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Australia's Fortrend shouldn't have disclosed employee medical record: privacy watchdog

By James Panichi ( September 23, 2025, 05:22 GMT | Insight) -- Fortrend Securities interfered with the privacy of an employee when it released medical records to a client to explain the worker’s decision to leave the company, Australia’s competition watchdog found. In a determination by the Australian Information Commissioner, The Melbourne-based investment company was found to have “engaged in conduct constituting an interference with the complainant’s privacy by disclosing the complainant’s medical certificate to a third party.” Fortrend was found to have acted in a way that was “malicious, improper and unjustifiable in the circumstances.”Investment company Fortrend Securities interfered with the privacy of an employee when it released medical records to a client to explain the worker’s decision to leave the company, Australia’s competition watchdog has found....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections